4.5 Article

Investigation of an outbreak of Salmonella enterica serovar Newport infection

期刊

EPIDEMIOLOGY AND INFECTION
卷 137, 期 10, 页码 1449-1456

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0950268809002416

关键词

Epidemiology; gastrointestinal disease; Salmonella

资金

  1. Environmental Health staff across Northern Ireland

向作者/读者索取更多资源

A large outbreak of Sahnonella enterica serotype Newport infection occurred in Northern Ireland during September and October 2004. Typing of isolates from patients confirmed that this strain was indistinguishable from that in concurrent Outbreaks in regions of England, in Scotland and in the Isle of Man. A total of 130 cases were distributed unequally across local government district areas in Northern Ireland. The epidemic Curve suggested a continued exposure over about 4 weeks. A matched case-control study of 23 cases and 39 controls found a statistically significant association with a history of having eaten lettuce in a meal outside the home and being a case (odds ratio 23.7, 95% confidence interval 1.4-404.3). This exposure was reported by 57% of cases. Although over 300 food samples were tested, none yielded any Sahnonella spp. Complexity and limited traceability in salad vegetable distribution hindered further investigation of the ultimate Source of the outbreak.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Urology & Nephrology

Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients

Peter Stenvinkel, Iain A. Gillespie, Jamie Tunks, Janet Addison, Florian Kronenberg, Tilman B. Drueke, Daniele Marcelli, Guntram Schernthaner, Kai-Uwe Eckardt, Juergen Floege, Marc Froissart, Stefan D. Anker

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Article Urology & Nephrology

High cardiovascular event rates occur within the first weeks of starting hemodialysis

Kai-Uwe Eckardt, Iain A. Gillespie, Florian Kronenberg, Sharon Richards, Peter Stenvinkel, Stefan D. Anker, David C. Wheeler, Angel L. de Francisco, Daniele Marcelli, Marc Froissart, Juergen Floege

KIDNEY INTERNATIONAL (2015)

Article Urology & Nephrology

Development and validation of a predictive mortality risk score from a European hemodialysis cohort

Juergen Floege, Iain A. Gillespie, Florian Kronenberg, Stefan D. Anker, Ioanna Gioni, Sharon Richards, Ronald L. Pisoni, Bruce M. Robinson, Daniele Marcelli, Marc Froissart, Kai-Uwe Eckardt

KIDNEY INTERNATIONAL (2015)

Article Public, Environmental & Occupational Health

Factors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover study

Iain A. Gillespie, Iain C. Macdougall, Sharon Richards, Vincent Jones, Daniele Marcelli, Marc Froissart, Kai-Uwe Eckardt

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)

Article Public, Environmental & Occupational Health

Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality

Iain A. Gillespie, Juergen Floege, Ioanna Gioni, Tilman B. Drueeke, Angel L. de Francisco, Stefan D. Anker, Yumi Kubo, David C. Wheeler, Marc Froissart

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)

Article Cardiac & Cardiovascular Systems

Development and validation of cardiovascular risk scores for haemodialysis patients

Stefan D. Anker, Iain A. Gillespie, Kai-Uwe Eckardt, Florian Kronenberg, Sharon Richards, Tilman B. Drueke, Peter Stenvinkel, Ronald L. Pisoni, Bruce M. Robinson, Daniele Marcelli, Marc Froissart, Juergen Floege

INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)

Article Urology & Nephrology

Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism

Angel Luis Martin de Francisco, Iain Andrew Gillespie, Ioanna Gioni, Juergen Floege, Florian Kronenberg, Daniele Marcelli, David Collins Wheelers, Marc Froissart, Tilman Bernhard Drueke

NEFROLOGIA (2016)

Article Medicine, General & Internal

The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients

Mary-Luz Rol, Fabienne Venet, Thomas Rimmele, Virginie Moucadel, Pierre Cortez, Laurence Quemeneur, David Gardiner, Andrew Griffiths, Alexandre Pachot, Julien Textoris, Guillaume Monneret

BMJ OPEN (2017)

Article Critical Care Medicine

Immune Profiling Demonstrates a Common Immune Signature of Delayed Acquired Immunodeficiency in Patients With Various Etiologies of Severe Injury*

Fabienne Venet, Julien Textoris, Sophie Blein, Mary-Luz Rol, Maxime Bodinier, Bertrand Canard, Pierre Cortez, Boris Meunier, Lionel K. Tan, Craig Tipple, Laurence Quemeneur, Frederic Reynier, Philippe Leissner, Christophe Vedrine, Yves Bouffard, Benjamin Delwarde, Olivier Martin, Thibaut Girardot, Cyrille Truc, Andrew D. Griffiths, Virginie Moucadel, Alexandre Pachot, Guillaume Monneret, Thomas Rimmele

Summary: This study comprehensively described the immune profile in critically ill patients with different etiologies and found that immune alterations in severely injured patients after admission were associated with increased risk of secondary infections.

CRITICAL CARE MEDICINE (2022)

Article Immunology

Herpes DNAemia and TTV Viraemia in Intensive Care Unit Critically Ill Patients: A Single-Centre Prospective Longitudinal Study

Francois Mallet, Lea Diouf, Boris Meunier, Magali Perret, Frederic Reynier, Philippe Leissner, Laurence Quemeneur, Andrew D. Griffiths, Virginie Moucadel, Alexandre Pachot, Fabienne Venet, Guillaume Monneret, Alain Lepape, Thomas Rimmele, Lionel K. Tan, Karen Brengel-Pesce, Julien Textoris

Summary: The study analyzed blood DNAemia of TTV and herpesviruses in critically ill patients, finding a higher prevalence of herpesvirus DNAemia in sepsis patients and a potential delay in the return of immune homeostasis associated with herpesvirus DNAemia. EBV and TTV may serve as additional markers to predict clinical deterioration in ICU patients.

FRONTIERS IN IMMUNOLOGY (2021)

Article Critical Care Medicine

A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST score

Jan-Alexis Tremblay, Florian Peron, Louis Kreitmann, Julien Textoris, Karen Brengel-Pesce, Anne-Claire Lukaszewicz, Laurence Quemeneur, Christophe Vedrine, Lionel K. Tan, Fabienne Venet, Thomas Rimmele, Guillaume Monneret

Summary: The study developed the REALIST score as a pragmatic approach to identify and stratify patients at high risk for secondary infection. It provides clinicians with a clear assessment of the immune status and could contribute to future trials of immune stimulation strategies.

ANNALS OF INTENSIVE CARE (2022)

Article Critical Care Medicine

Immune Profiling Panel Gene Set Identifies Critically Ill Patients With Low Monocyte Human Leukocyte Antigen-DR Expression: Preliminary Results From the REAnimation Low Immune Status Marker (REALISM) Study

Estelle Peronnet, Sophie Blein, Fabienne Venet, Elisabeth Cerrato, Aurore Fleurie, Jean-Francois Llitjos, Louis Kreitmann, Gabriel Terraz, Filippo Conti, Morgane Gossez, Thomas Rimmele, Julien Textoris, Anne-Claire Lukaszewicz, Karen Brengel-Pesce, Guillaume Monneret

Summary: This study evaluated the ability of a prototype multiplex polymerase chain reaction tool (IPP) to identify immunosuppressed ICU patients. The IPP gene set showed high accuracy and specificity in identifying patients who would benefit from immunostimulation therapy in personalized medicine.

CRITICAL CARE MEDICINE (2023)

Correction Infectious Diseases

Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies (27 Sep, 10.1007/s40121-023-00824-y, 2023)

Iain A. Gillespie, Eleanor Barnes, Ian C. K. Wong, Philippa C. Matthews, Graham S. Cooke, Craig Tipple, Robert C. Elston, Yunhao Liu, David A. Smith, Tingyan Wang, Jim Davies, Kinga A. Varnai, Oliver Freeman, Kenneth K. C. Man, Wallis C. Y. Lau, Ben Glampson, Xing Meng, Eleonora Morais, Sen Liu, Luca Mercuri, Naomi Boxall, Sarah Jenner, Stuart Kendrick, Jane Dong, Dickens Theodore

INFECTIOUS DISEASES AND THERAPY (2023)

Article Infectious Diseases

Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies

Iain A. A. Gillespie, Eleanor Barnes, Ian C. K. Wong, Philippa C. C. Matthews, Graham S. S. Cooke, Craig Tipple, Robert C. C. Elston, Yunhao Liu, David A. A. Smith, Tingyan Wang, Jim Davies, Kinga A. A. Varnai, Oliver Freeman, Kenneth K. C. Man, Wallis C. Y. Lau, Ben Glampson, Xing Meng, Eleonora Morais, Sen Liu, Luca Mercuri, Naomi Boxall, Sarah Jenner, Stuart Kendrick, Jane Dong, Dickens Theodore

Summary: This study aimed to characterize patients with chronic HBV infection across different continents and determine their treatment need. The results showed that a considerable proportion of patients who were indicated for treatment were currently untreated, including many patients with fibrosis/cirrhosis.

INFECTIOUS DISEASES AND THERAPY (2023)

Article Pharmacology & Pharmacy

Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study

Myriam Drysdale, Radmila Choate, Amanda E. Brunton, Simon Tiberi, Iain A. Gillespie, Noah Lininger, Susan B. Shrimpton, Mark Metersky, Nicole C. Lapinel, Pamela J. McShane, Christopher J. Richards, Colin Swenson, Hema Sharma, David Mannino, Bronchiectasis Investigator, NTM Res Registry Investigator

Summary: This study described the epidemiology, patient management, and treatment outcomes of nontuberculous mycobacterial (NTM) infections in patients with bronchiectasis enrolled in the United States Bronchiectasis and NTM Research Registry. The study found that a considerable proportion of NTM infections in these patients were untreated or treated after initial delay/observation, and MABSC infections were more likely to be treated and start treatment sooner than MAC infections.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2023)

暂无数据